HFM
ABEO icon

Hartford Financial Management’s Abeona Therapeutics ABEO Stock Holding History

Hartford Financial Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-720
Closed -$5.22K – 396
2024
Q1 		$5.22K Hold
720
– – ﹤0.01% 330
2023
Q4 		$3.61K Hold
720
– – ﹤0.01% 346
2023
Q3 		$3.03K Hold
720
– – ﹤0.01% 350
2023
Q2 		$2.9K Sell
720
-27
-4% -$94 ﹤0.01% 331
2023
Q1 		$2.11K Hold
747
– – ﹤0.01% 346
2022
Q4 		$2.3K Hold
747
– – ﹤0.01% 341
2022
Q3 		$2K Hold
747
– – ﹤0.01% 345
2022
Q2 		$4K Hold
747
– – ﹤0.01% 327
2022
Q1 		$6K Buy
+747
New +$5.13K ﹤0.01% 314
2021
Q4 		– Sell
-27
Closed -$1K – 359
2021
Q3 		$1K Sell
27
-40
-60% -$1.28K ﹤0.01% 384
2021
Q2 		$3K Sell
67
-187
-74% -$7.63K ﹤0.01% 344
2021
Q1 		$12K Hold
254
– – ﹤0.01% 285
2020
Q4 		$10K Hold
254
– – ﹤0.01% 284
2020
Q3 		$6K Sell
254
-814
-76% -$51.3K ﹤0.01% 283
2020
Q2 		$78K Hold
1,068
– – 0.02% 174
2020
Q1 		$56K Buy
1,068
+50
+5% +$3.34K 0.02% 179
2019
Q4 		$83K Sell
1,018
-212
-17% -$15K 0.03% 190
2019
Q3 		$70K Buy
1,230
+180
+17% +$13.5K 0.02% 194
2019
Q2 		$125K Hold
1,050
– – 0.04% 171
2019
Q1 		$193K Buy
1,050
+12
+1% +$2.15K 0.07% 154
2018
Q4 		$185K Sell
1,038
-20
-2% -$4.36K 0.07% 151
2018
Q3 		$339K Buy
1,058
+180
+21% +$63.9K 0.11% 130
2018
Q2 		$351K Buy
878
+7
+0.8% +$3.06K 0.13% 129
2018
Q1 		$312K Buy
871
+67
+8% +$24.9K 0.16% 100
2017
Q4 		$318K Buy
804
+40
+5% +$16.5K 0.16% 101
2017
Q3 		$325K Buy
764
+48
+7% +$12.9K 0.16% 97
2017
Q2 		$114K Hold
716
– – 0.05% 156
2017
Q1 		$89K Buy
716
+324
+83% +$41.8K 0.05% 153
2016
Q4 		$48K Buy
392
+300
+326% +$47K 0.03% 157
2016
Q3 		$13K Hold
92
– – 0.01% 215
2016
Q2 		$5K Buy
+92
New +$6.29K ﹤0.01% 249

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Hartford Financial Management's ABEO Position: Q2 2024 in Review

Hartford Financial Management sold out of Abeona Therapeutics (ABEO) in Q2 2024, closing a stake of 720 shares — an estimated $5.22K sold.

Hartford Financial Management first reported a position in ABEO in Q2 2016 and held it in 31 quarters. The position peaked at $351K in Q2 2018. 48 funds tracked by Wall St. Rank hold ABEO as of Q2 2024.

  • Hartford Financial Management reported no remaining Abeona Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Hartford Financial Management sold 720 Abeona Therapeutics shares in Q2 2024, an estimated $5.22K.
  • Hartford Financial Management first reported a position in Abeona Therapeutics in Q2 2016 and held it in 31 quarters.
  • Hartford Financial Management's Abeona Therapeutics position peaked at $351K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2024.

Based on Hartford Financial Management's 13F filing for Q2 2024, filed 9 Aug 2024.